THOUSAND OAKS BIOPHARMACEUTICALS
Thousand Oaks Biopharmaceuticals is a developer of biopharmaceutical technologies intended to produce protein and vaccine compounds. The company's technologies provide integrated control solutions, including the use of technical expertise to optimize the process and increase protein expression to reduce production scale, providing bio-pharmaceutical companies with personalized, chemical-defined cell culture media, formula production, technical support and ancillary services.
THOUSAND OAKS BIOPHARMACEUTICALS
Social Links:
Industry:
Biopharma Biotechnology Health Care
Founded:
2017-03-01
Status:
Active
Contact:
+86 0513-68067603
Email Addresses:
[email protected]
Total Funding:
2.2 B CNY
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Google Font API Content Delivery Network SSL By Default Mobile Non Scaleable Content Pound Sterling ASP.NET
Similar Organizations
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Nodexus
Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Transcenta
Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture.
Tridiuum
Tridiuum is a digital health company that is advancing the treatment of behavioral health conditions.
Current Employees Featured
Founder
Investors List
Timesbole
Timesbole investment in Venture Round - Thousand Oaks Biopharmaceuticals
CDH Investments
CDH Investments investment in Series D - Thousand Oaks Biopharmaceuticals
Highlight Capital
Highlight Capital investment in Series D - Thousand Oaks Biopharmaceuticals
GoldStone Investment
GoldStone Investment investment in Series D - Thousand Oaks Biopharmaceuticals
Hillhouse Investment
Hillhouse Investment investment in Series D - Thousand Oaks Biopharmaceuticals
Jinshi Investment
Jinshi Investment investment in Series C - Thousand Oaks Biopharmaceuticals
China State-Owned Capital Venture Investment Fund
China State-Owned Capital Venture Investment Fund investment in Series C - Thousand Oaks Biopharmaceuticals
CDH Investments
CDH Investments investment in Series C - Thousand Oaks Biopharmaceuticals
Honghui Capital
Honghui Capital investment in Series C - Thousand Oaks Biopharmaceuticals
GL Ventures LLC
GL Ventures LLC investment in Series C - Thousand Oaks Biopharmaceuticals
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-01-17 | MabPlex International | Thousand Oaks Biopharmaceuticals investment in Series A - MabPlex International | 400 M CNY |
More informations about "Thousand Oaks Biopharmaceuticals"
Thousand Oaks Biopharmaceuticals - PitchBook
Thousand Oaks Biopharmaceuticals General Information Description. Operator of a chemistry, manufacturing and controls (CMC) organization. The company offers contract development โฆSee details»
Shun Luo - Chairman, Founder and CEO, Thousand โฆ
Dr Shun Luo, chairman, founder and CEO of Thousand Oaks Biopharmaceuticals, shares the companyโs vision to deliver more accessible and affordable biologics to patients globally by lowering the cost of goods โฆSee details»
Thousand Oaks Biopharmaceuticals Group, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Thousand Oaks Biopharmaceuticals Group, Inc. of Pleasanton, CA. Get the latest business insights from โฆSee details»
Thousand Oaks Biopharmaceuticals Completes $45 Million Series โฆ
Jan 3, 2019 Thousand Oaks Biopharmaceuticals is a world-class integrated CMC organization which enables its partners to provide affordable and accessible biologics for patients worldwide.See details»
Thousand Oaks Biopharmaceuticals - Funding, Financials, โฆ
Thousand Oaks Biopharmaceuticals is a developer of biopharmaceutical technologies intended to produce protein and vaccine compounds. New. Resources. Advanced Search. ... How much โฆSee details»
China CDMO Thousand Oaks raises $240m - AVCJ
Nov 10, 2023 Thousand Oaks Biopharmaceuticals, a China-based contract development and manufacturing organization (CDMO), has raised CNY 1.5bn (USD 240m) in funding led by โฆSee details»
Thousand Oaks Biopharmaceuticals Company Profile - Craft
Thousand Oaks Biopharmaceuticals has 5 employees across 2 locations and $107.6 m in total funding,. See insights on Thousand Oaks Biopharmaceuticals including office locations, โฆSee details»
Thousand Oaks Biopharmaceuticals, Inc. | VentureRadar
It integrated a leading cell culture media supplier, JSBio, which is the 1st serum-free cell culture media supplier in China, founded in 2011, with expanding capabilities to supply cell culture โฆSee details»
Thousand Oaks Biopharmaceuticals (ๆพณๆฏๅบท) - Tech in Asia
Thousand Oaks Biopharmaceuticals (ๆพณๆฏๅบท) Nantong Pt, China. Bio-Pharm. 501 โ 1,000. Thousand Oaks Biopharmaceuticals is an integrated CMC organization that focuses on โฆSee details»
Thousand Oaks Biopharmaceuticals Completes $45 Million Series
Jan 11, 2019 Thousand Oaks Biopharmaceuticals, Inc. (โTOBIOโ), a leading integrated global CMC organization including GMP cell culture media and biomanufacturing capabilities today โฆSee details»
Thousand Oaks Biologics, Inc. - Drug pipelines, Patents, Clinical ...
TOBio is a cutting-edge global biopharmaceutical development and manufacturing organization, whose CMC capabilities in biologics are widely acknowledged. ... that will empower the CDMO โฆSee details»
Thousand Oaks Biopharmaceuticals, Inc. - CMOCRO - Domain Name
Thousand Oaks Biopharmaceuticals is a developer of biopharmaceutical technologies intended to produce protein and vaccine compounds. The company\\'s technologies provide integrated โฆSee details»
Thousand Oaks Biopharmaceuticals - Contacts, Employees, Board โฆ
Thousand Oaks Biopharmaceuticals is a developer of biopharmaceutical technologies intended to produce protein and vaccine compounds.See details»
Thousand Oaks Biologics and GeneQuantum Healthcare Signed A โฆ
May 22, 2023 TOBio is a cutting-edge global biopharmaceutical development and manufacturing organization, whose CMC capabilities in biologics are widely acknowledged. ... About โฆSee details»
Thousand Oaks Biopharmaceuticals Completes $45 Million Series โฆ
Jan 4, 2019 THOUSAND OAKS, Calif. & SHANGHAI--(BUSINESS WIRE)--Thousand Oaks Biopharmaceuticals, Inc. (โTOBIOโ), a leading integrated global CMC organization including โฆSee details»
Thousand OAKS Biopharma Secures Series A Total at USD 44 Million
January 1, 2019 /EqualOcean/ - Thousand OAKS Biopharmaceuticals(TOAKSB) just completed its series A funding total at CNY 300 million (USD 44 million) led by New Alliance Capital and โฆSee details»
Thousand Oaks Raises ๏ฟฅ400M in Series C Financing - vbdata.cn
(VCBeat) Mar. 10, 2021 -- Thousand Oaks Biopharmaceuticals ("Thousand Oaks"), a rapidly-growing contract development and manufacturing organization (CDMO) engaged in culture โฆSee details»
Thousand Oaks Bio Completes $235 Million Round for CDMO Ops
Jan 14, 2022 Thousand Oaks Biopharma, headquartered in Nantong, completed a $235 million Series D financing to support its biologic CDMO operations. In 2017, TOBio was founded โฆSee details»
Thousand Oaks Biologics and GeneQuantum Healthcare Signed A โฆ
May 22, 2023 Thousand Oaks Biologics Inc. and GeneQuantum Healthcare Co., ... TOBio is a cutting-edge global biopharmaceutical development and manufacturing organization, whose โฆSee details»
Thousand Oaks, Ventura 'Hands Off!' protests draw thousands
1 day ago Organizers counted around 1,300 sign-ups before the event, but they estimate more than 2,000 attendees showed up to the intersection from 1 p.m. to 3 p.m., Brand said.See details»